Dysregulation of MET signaling-mediated proliferation, cell death, and migration through overexpression of MET protein and amplification or mutation of the MET gene has been demonstrated in oncogenic processes across several tumor types and has been steadily reported [27–31]. The gene discussed is MET; the disease is neoplasm.